ClpX functions as either an independent chaperone or a component of the ClpXP protease, a conserved intracellular protease that acts as a global regulator in the bacterial cell by degrading regulatory proteins, stress response proteins and ratelimiting enzymes. Previously, we found that loss of clpX in Bacillus anthracis Sterne leads to increased susceptibility to antimicrobial agents that target the cell envelope. The aim of this study was to identify genes within the regulatory network of clpX that contribute to antimicrobial resistance. Using microarray analysis, we found 119 genes that are highly differentially expressed in the DclpX mutant, with the majority involved in metabolic, transport or regulatory functions. Several of these differentially expressed genes, including glpF, sigM, mrsA, lrgA and lrgB, are associated with cell wall-active antibiotics in other bacterial species. We focused on lrgA and lrgB, which form the lrgAB operon and are downregulated in DclpX, because loss of lrgAB increases autolytic activity and penicillin susceptibility in Staphylococcus aureus. While we observed no changes in autolytic activity in either DclpX or DlrgAB B. anthracis Sterne, we find that both mutants have increased susceptibility to the antimicrobial peptide LL-37 and daptomycin. However, phenotypes between DclpX and DlrgAB are not identical as DclpX also displays increased susceptibility to penicillin and nisin but DlrgAB does not. Therefore, while decreased expression of lrgAB may be partially responsible for the increased antimicrobial susceptibility seen in the DclpX mutant, disruption of other pathways must also contribute to this phenotype.
INTRODUCTION
Bacillus anthracis, the causative agent of the deadly disease anthrax, is a Gram-positive, spore-forming bacterium. Anthrax manifests when bacterial endospores enter the body through abrasions in the skin, the gastrointestinal tract or the respiratory tract. Because of the relative ease of spore dispersal and the bacterium's ability to cause fatal disease, it has long been regarded as a potential bioterrorism threat [1] . B. anthracis expresses a number of critical virulence factors including the toxins, lethal and oedema toxin, and capsule, encoded on the pXO1 and pXO2 plasmids, respectively [2] . However, chromosomally encoded genes may also contribute to virulence, and sequencing of the B. anthracis genome has revealed homologues to a number of putative virulence genes [3] . Among these genes, we identified the chromosomally encoded clpX gene as necessary for virulence in B. anthracis, including in the fully virulent, encapsulated Ames strain [4] .
ClpX is a regulatory ATPase that can function either as an independent chaperone or in conjunction with a proteolytic core, ClpP, to form the caseinolytic (Clp) protease ClpXP [5] . ClpXP controls the stability of several transcriptional regulators [6, 7] and, accordingly, inactivation of this protease impacts the expression of a large number of genes involved in diverse cellular processes [8] [9] [10] . Loss of either clpX or clpP can increase susceptibility to stress and decrease virulence in a number of pathogens [5, 7] . Because of this, the Clp protease is recognized as a promising antibacterial target [11] .
We previously found that loss of clpX increases susceptibility to antimicrobials that target the cell membrane and/or cell wall, collectively known as the cell envelope. This includes LL-37, a member of the cathelicidin family of antimicrobial peptides (AMPs), and the antibiotics penicillin and daptomycin [4, 12] . Although loss of clpX in B. anthracis leads to increased susceptibility to cell envelope-targeting antimicrobials, the exact mechanism behind this phenotype is unknown. To gain a better understanding of the regulatory network of ClpX, we utilized microarray analysis to examine differences in global gene expression between wildtype and DclpX B. anthracis Sterne. This approach identified 119 genes that are highly up-or downregulated in DclpX B. anthracis. In this study, we focus on the role of two genes, lrgA and lrgB, that form the dicistronic lrgAB operon and are downregulated in DclpX.
METHODS
Bacterial strains and culture conditions Unless otherwise noted, cultures of B. anthracis Sterne strain (pXO1 + pXO2 -) were grown in brain-heart infusion (BHI) media (Hardy Diagnostics) at 37 C under aerobic conditions. Antibiotic selection was used at the following concentrations: 5 µg ml À1 of erythromycin, 10 µg ml À1 chloramphenicol and 100 µg ml À1 spectinomycin (all Sigma). Construction of DclpX B. anthracis Sterne was described previously [4] . All other strains were constructed during this study and are described below.
RNA purification
Three independent cultures from wild-type B. anthracis Sterne and DclpX were grown to early log phase in BHI.
Cultures were pelleted and resuspended in 200 µl of water. Four hundred microlitres of RLT buffer from the RNeasy Mini kit (Qiagen) was added and the solution was transferred to a 2 ml vial containing 0.1 mm disruptor beads (BioExpress). Cells were mechanically disrupted using the Fast Prep-24 (MP Biomedicals), with two pulses at 6 m s
À1
for 45 s and a 2 min rest on ice between pulses. The supernatant was transferred to a new tube, 250 µl of ethanol was added and the sample was applied to the RNeasy column and extraction proceeded as per the manufacturer's protocol, including the extra RNA elution step. The RNA was treated with two rounds of DNase treatment using the TURBO DNA-free Kit (Thermo Fisher Scientific). RNA used for microarray analysis was further concentrated using the Clean and Concentrator-5 kit (Zymo Research).
Microarray
RNA was sent to Ambry Genetics for processing and microarray analysis. Double-stranded cDNA was synthesized utilizing the Roche cDNA Synthesis System for use with the NimbleGen Gene Expression Microarrays. One-colour labelling reactions were prepared using the Roche NimbleGen Gene expression protocol (version 5.1) with 5 µg total RNA input. RNA was converted to double-stranded cDNA using an oligo (dT) primer. The double-stranded cDNA was then labelled with Cy-3 Random Nonamers by Exo-Klenow fragment. Labelled cDNA was purified by ethanol precipitation, and the labelling efficiency was determined by the NanoDrop Spectrophotometer. Next, 3 µg of labelled cDNA was prepared for hybridization, placed on the B. anthracis Sterne 385K gene expression microarray and hybridized for 16-20 h at 42 C using a Maui hybridization system. Finally, the arrays were washed and scanned at 5 µM resolution on a NimbleGen MS 200 High Resolution Scanner. Data were processed through NimbeScan2.6 using the 2006-07-27_T1260799_60mer design files. The NimbleScan software normalized the expression data using quantile normalization after raw intensity values were background corrected [13] . Three independent arrays for wild-type and DclpX expression were run (6 arrays total). The data presented in this publication have been deposited in NCBI's Gene Expression Omnibus and are accessible through GEO Series accession number GSE94398 (https://www.ncbi.nlm.nih. gov/geo/query/acc.cgi?acc=GSE94398).
Statistical analysis and bioinformatics
Corrected intensity values were imported into R statistical software for analysis. Briefly, a general linear model approach was taken to identify differentially expressed transcripts between DclpX and wild-type, and we corrected for false-positives by including a Benjamini-Hochberg false discovery rate (FDR) (alpha=0.001) [14] . Differentially expressed transcripts were deemed up or down-regulated in the DclpX mutant when there was a minimum log 2 fold change in expression of 2 and a FDR corrected P-value <0.001. Functionality of the transcripts was inferred by gene ontology (GO) mapping using Blast2GO (v. 4.1.9). GO terms were mapped to all protein-coding sequences on the B. anthracis Sterne 385K gene expression microarray using a minimum e-value of 1.0Â10
À10
. QPCR RNA was extracted as described above. cDNA was made from 2 µg extracted RNA using the High Efficiency cDNA Synthesis Kit (Thermo Fisher Scientific). QPCR amplification was carried out using SYBR Green PCR Mix (Thermo Fisher Scientific), with 1 µl cDNA and 0.25 µM forward and reverse primers in a final volume of 20 µl using the 7500 Real-Time PCR System (Applied Biosystems). Cycling conditions were 1 cycle of 50 C for 2 min then 95 C for 10 min, followed by 40 cycles of 95 C for 15 s and 60 C for 1 min. Amplification efficiency for all primers is near 100 % (±10 %) under the conditions used. Relative expression of genes was calculated using the Livak method [15] and normalized to the reference gene FusA. Primers used were FusA fwd (5¢-AAGCTGGTGGTGC TGAAGCAC-3¢); FusA rev (5¢-CCATTTGAGCAGCAC-CAGTGA-3¢); LrgA Fwd (5¢-CCAATTCCAATGCCCTCA TC-3¢); LrgA Rev (5¢-CTGAAATACCTGATGGGACG-3¢); LrgB Fwd (5¢-ATCTCTGAAAGCATTGGTGG-3¢); LrgB Rev (5¢-GCATTAGGAGTGGCAGTAGG-3¢); LytR Fwd (5¢-ACGATGGACACGCATGAAAC-3¢); LytR Rev (5¢-ATATG TAGGGCTTGTGGACG-3¢); LytS Fwd (5¢-CTATCGTCG GAATTGGAGTAGG-3¢); LytS Rev (5¢-GAAGAGATCGCG CAACTTAGC-3¢); CidR Fwd (5¢-CGAGGGTATCTG TTGCGTTACATGA-3¢); and CidR Rev (5¢-TGTGTTGGGA TTGGTGGACG-3¢). All experiments were performed with at least three independent RNA preparations, and results are presented as the mean ± the standard error of the mean (SEM).
Construction of DlrgAB isogenic mutant and complemented strains
Approximately 1000 bp of DNA immediately upstream of lrgAB was amplified with primers UpLrgABFwd (5¢-ATGC TCGAGGACAAGGGATTGAGGAAGAACG-3¢) and UpLr gABRev (5¢-CCAGTGATTTTTTTCTCCATTTTGGCCACC TCTTTCGATTTGGTACC-3¢), while a DNA fragment of approximately 1000 bp immediately downstream of lrgAB was amplified with primers DnLrgABFwd (5¢-TGGCAGG GCGGGGCGTAAAGCAAGCTATTTGTAGGACAGATTT CT-3¢) and DnLrgABRev (5¢-CATGGATCCCAACGA TGCGAGCTTTCTCC-3¢). The 5¢ ends of primers UpLrg ABRev and DnLrgABFwd were engineered with 20 bp extensions corresponding to the 5¢ and 3¢ ends of the chloramphenicol acetyl transferase (cat) gene. A 660 bp amplicon of the complete cat gene was amplified using catFwd (5¢-A TGGAGAAAAAAATCACTGGATATACCA-3¢) and catRev (5¢-TTACGCCCCGCCCTGC-3¢), and then combined with the upstream and downstream products as templates for a second PCR reaction using primers UpLrgABFwd and DnLrgABRev and PCR-based fusion [16] . The resulting amplicon was subcloned into the temperature-sensitive plasmid pHY304 [17] , a derivative of pVE6007 [18] , using Xhol and BamHI restriction endonucleases. The construct was transformed into B. anthracis Sterne, and transformants were grown at 30 C and then shifted to 37 C under erythromycin selection to identify single-crossover events. Colonies with single crossovers in both orientations were grown overnight in media containing chloramphenicol at 30 C, passed once at 30 C and then plated on BHI chloramphenicol plates at an appropriate dilution to generate single colonies and grown overnight at 37 C. Colonies with double-crossover events were identified by selecting for colonies that exhibited chloramphenicol resistance but erythromycin sensitivity, and confirmed using PCR.
The expression plasmid plrgAB was constructed by amplifying the complete lrgAB sequence using primers LrgABEVFwd 5¢-ATGCGTCGACTAACTGATTCTGTATATTT GACGTTCCGT-3¢and LrgABEVRev 5¢-TGCAGCATGC TAAAAGAGGTCTTACCACTACTGTAACAT-3¢, and the expression plasmid pclpX was constructed by amplifying the complete clpX sequence using the primers ClpXEV Fwd 5¢-AGCTGTCGACTCGTGTACATACGAAGGCAAGAG-3¢ and ClpXEV Rev 5¢-TCGTGCATGCTCCGCGGAGGAA-CATAGCTA-3¢. The amplicons were then sub-cloned into pUTE657 [19] . The expression plasmids were then transformed into the DlrgAB and/or DclpX isogenic mutants and selected for using spectinomycin. As controls for the plasmid, empty pUTE657 was transformed into the parental, DlrgAB and DclpX, isogenic mutants.
Assays for autolytic activity
Murein hydrolases were extracted as described in [20] , but briefly cultures were pelleted, resuspended in sample buffer and then boiled for 3 min. Samples were analysed by zymography as described in [21] , with the exception that the SDS-PAGE gels were embedded with 10 mg ml À1 of lyophilized B. anthracis Sterne cells. For autolysis assays, early log phase cultures were grown to an optical density (OD) of 0.4 at 600 nm wavelength, and stationary phase cultures were grown overnight (16 h) in BHI. Cultures were pelleted and washed twice in 10 mM sodium phosphate buffer (pH 7.0) and once in cold water. Bacteria were then resuspended in sodium phosphate buffer with 0.05 % Triton X-100 (Sigma) and incubated at 37 C. Bacterial lysis was measured by reading the optical density (OD) at 600 nm wavelength at least once per hour for a minimum of 6 h.
Antimicrobial susceptibility assays
Overnight cultures were diluted 1 : 20 and grown to early log phase at an OD of 0.4 at 600 nm wavelength. Cultures were pelleted, washed and re-suspended in an equivalent volume of PBS and diluted 1 : 20 in the appropriate assay media. For testing LL-37, assays were performed in Roswell Park Memorial Institute RPMI 1640 medium (Corning) supplemented with 5 % Luria-Bertani medium (Hardy Diagnostics) and incubated in LL-37 (Anaspec) at the indicated concentrations. For testing of daptomycin, B. anthracis Sterne was grown in Mueller-Hinton Broth II supplemented with 50 µg ml À1 calcium, and incubated with daptomycin (Cubist pharmaceuticals) at indicated concentrations. Assays using nisin and penicillin (both Sigma) were performed in BHI at the indicated concentrations. For the complementation analyses, media was supplemented with 0.1 mM IPTG to induce expression of pUTE657. Assays were performed in 96-well plates, which were incubated overnight for 16 h at 37 C under static conditions except for the daptomycin assays comparing DclpX and DlrgAB, which were incubated in culture tubes overnight for 16 h at 37 C shaking. Following incubation, the OD of each well was measured at 600 nm wavelength. Data are presented as the mean of at least three independent experiments ± SEM.
RESULTS

Loss of clpX affects global gene expression
Loss of ClpX affects a wide range of genes and proteins, including transcriptional regulators [6, 8, 10] . Therefore, we investigated how the loss of clpX affects global gene expression in B. anthracis Sterne by performing microarray analysis comparing gene expression of 5287 chromosomal genes between the parental wild-type and DclpX mutant. In Fig. 1 , we plotted the log 10 P-value as a function of the log 2 -foldchange in expression for each gene. We set stringent foldchange and P-value criteria to focus on genes that are most likely to be biologically relevant. Green dots represent genes that have at least a log 2 -fold change in expression of 2 and are statistically significant (FDR corrected P-value <0.001), with 49 genes that are downregulated in DclpX shown on the left of the graph and 70 genes that are upregulated on the right. Black dots represent genes that had no change in expression (3860 genes), and red dots represent genes that were differentially expressed less than a log 2 -fold change in expression of 2 (1307 genes). The gene locus of genes with highly changed expression (log 2 -fold change of 2.8 or more) is shown in Fig. 1 next to the corresponding dot. BAS2596-BAS2600 and BAS2836 were very highly upregulated in the DclpX mutant (log 2 -fold change of 7 or more). BAS2836 is a hypothetical protein and no further information is available regarding its predicted function. BAS2596-BAS26000 are located next to each other in the genome, but they are not coordinately regulated within the same operon as BAS2598 is located on the opposite DNA strand to the other genes. BAS2596, BAS2597 and BAS2598 are part of a glycine betaine/L-proline ABC transporter system with no immediately apparent link to antibiotic resistance. BAS2599 and BAS2600 belong to clpP2 and an RNA polymerase sigma-70 Fig. 1 . Volcano plot showing log 2 -fold change (FC) and -log 10 FDR corrected P-value. Points in black represent genes that show no sign of being differentially expressed. Red points represent genes that show less than a log 2 2-fold difference in expression between DclpX and wild-type. Green points represent genes with an FDR corrected P-value <0.001 and greater than a log 2 2-fold change in expression between DclpX and wild-type. Genes with more than a log 2 2.8-fold difference in expression between DclpX and wild-type are annotated.
factor, respectively and may form a dicistronic operon based on their position in the genome. While this appears to indicate that ClpX can regulate its partner protein, it is important to note that B. anthracis is unique among many Gram-positive bacteria in that it contains two clpP genes [12] . Loss of clpX results in increased expression of clpP2 (BAS2599), but the expression of clpP1 (BAS5000) is unchanged. We also performed GO mapping to investigate the functional significance of the 119 genes represented by the green dots. Genes are organized by their general functionality and the specific gene locus, gene description and the gene name (if known) are included in Table 1 (upregulated genes) and (Table S1 , available in the online version of this article). Raw data from the entire microarray can be accessed at NCBI's Gene Expression Omnibus through GEO Series accession number GSE94398.
Nearly 30 % of the 119 differentially expressed genes were hypothetical proteins of unknown function (35 genes). Of the remaining 84 genes, we found 5 genes, glpF, msrA, sigM, lrgA and lrgB, with previously reported links to cell wallactive antibiotics. Mutations in glpF, which is involved in glycerol uptake, has been linked to loss of ampicillin persistence in Staphylococcus aureus [22] . The methionine sulfoxide reductase gene msrA is induced by cell wall-active antibiotics in S. aureus [23] , and sigM is necessary for resistance to b-lactam antibiotics in Bacillus subtilis [24] . Lastly, lrgA and lrgB, which form the dicistronic lrgAB operon, have been linked to autolysis and penicillin tolerance in S. aureus [21] . In DclpX B. anthracis Sterne, glpF, sigM and lrgAB are all downregulated while msrA is upregulated relative to wildtype (Tables 1 and 2 ). We focused on lrgAB because of the possible mechanistic connection between the regulation of cell wall homeostasis [21] and the increased susceptibility to cell wall-active agents observed in DclpX [4, 12] .
LrgA is described as an antiholin-like protein due to structural similarities to bacteriophage-encoded antiholins [21] . Antiholins antagonize holins, which oligomerize to form non-specific holes in the cell membrane that release bacteriophage-encoded murein hydrolases during viral exit [21, 25] . LrgA is also associated with the membrane and has the ability to oligomerize into high-molecular mass complexes [26] . Consistent with this model, deletion of lrgAB in S. aureus increases the activity of murein hydrolases and increases susceptibility to penicillin-induced killing [21] . Therefore, we hypothesized that the loss of clpX leads to the downregulation of lrgAB, which in turn increases autolytic activity and contributes to the increased sensitivity to LL-37 and daptomycin seen in DclpX B. anthracis Sterne [4, 12] .
We first confirmed repression of lrgA and lrgB in the DclpX mutant using quantitative polymerase chain reaction (QPCR) and found a statistically significant decrease in expression (Fig. 2) . Highest expression levels of lrgAB occur during lag and early log phase growth [27] , which is the growth phase used in our microarray and QPCR experiments. Two transcriptional regulators of lrgAB have been identified, LytSR, a two-component regulatory system, and CidR. Deletion of either reduces lrgAB expression in B. anthracis Sterne [27, 28] . We checked whether expression of either of these transcriptional regulators was decreased in our DclpX mutant, as disruption of these genes could explain the loss of lrgAB expression. Expression levels in our microarray showed no difference in expression for lytS, lytR or cidR in the DclpX mutant. No decrease in expression for lytS, lytR or cidR is seen in our QPCR data either (Fig. 2) . If anything, there is a slight increase in expression although these differences were not statistically significant. Therefore, clpX is not necessary for the transcriptional regulation of either lytSR or cidR, although it is necessary for normal regulation of lrgAB expression.
No change in autolytic activity is seen in DlrgAB or
DclpX B. anthracis Sterne Because LrgAB has previously been described as a negative regulator of autolysis, we tested whether deletion of lrgAB or clpX resulted in changes in autolytic activity. Although a deletion of lrgAB in B. anthracis Sterne has been constructed previously [28] , we generated a novel isogenic DlrgAB mutant in the same parental Sterne strain as our DclpX mutant to allow for direct comparison of the phenotypes in the two mutants. We saw no change in triton-induced autolysis of DlrgAB or DclpX in comparison to the wild-type B. anthracis Sterne with either log or stationary phase cultures (Fig. S1) , and no change in murein hydrolase activity with the DclpX mutant (Fig. S2) . This is comparable to the results seen by Chandramohan et al., who saw no changes in lysis or murein hydrolase activity in their DlrgAB mutant [28] . Therefore, loss of neither lrgAB nor clpX has a discernible effect on autolytic activity in B. anthracis Sterne under our assay conditions.
Deletion of lrgAB in B. anthracis increases antimicrobial susceptibility
We next tested whether loss of lrgAB increased susceptibility of B. anthracis Sterne to cell envelope-targeting antimicrobials, since LrgAB could be mediating aspects of cell envelope structure/function other than autolytic activity. To ensure there were no unintended polar effects due to the deletion of lrgAB, complementation was achieved by restoring the lrgAB genes in trans using the inducible plasmid pUTE657 [19] generating the expression plasmid plrgAB. To control for any effects of the plasmid, wild-type B. anthracis Sterne and DlrgAB were transformed with empty pUTE657. We incubated wild-type B. anthracis Sterne containing pUTE657, the DlrgAB mutant containing pUTE657 and the complemented DlrgAB containing plrgAB in the presence of the human cathelicidin LL-37 or daptomycin overnight at 37 C. Media used throughout the experiment, including overnight cultures, early log cultures and assay media, were supplemented with 0.1 mM IPTG to induce expression of plrgAB; 0.1 mM IPTG is the lowest dose we observed that induced complementation (data not shown), and it was applied to all treatments to control for any effects of the IPTG itself. No growth inhibition was seen in untreated media (data not shown), but growth of DlrgAB was significantly inhibited compared to both the wild-type and complemented strain in the presence of LL-37 and daptomycin (Fig. 3) , indicating that deletion of lrgAB increases B. anthracis Sterne sensitivity to both of these antimicrobials.
DclpX and DlrgAB have similar but not identical phenotypes
We directly compared the responses of DclpX and DlrgAB to the cell envelope-acting antimicrobial peptides LL-37 and nisin, and the antibiotics daptomycin and penicillin. Both DclpX and DlrgAB show increased susceptibility to LL-37 and daptomycin, but their responses are not identical and DclpX has a stronger phenotype (Fig. 4) . This is particularly noticeable for daptomycin, in which the growth of DclpX but not DlrgAB is inhibited at a concentration of 3 µg ml À1 . At 4 µg ml À1 daptomycin, both DclpX and DlrgAB are inhibited relative to wild-type. However, even at 4 µg ml À1 daptomycin or 1.6 µM LL-37 when the growth of DclpX is completely inhibited, there is a small amount of growth seen with the DlrgAB mutant, although it is still significantly less than growth in the wild-type. Loss of clpX also inhibits growth in both nisin and penicillin, but we see no effect with loss of lrgAB for either antimicrobial at any concentration we tried (Fig. 4) . No difference in growth curves between parental wild-type, DclpX and DlrgAB were seen in any of the untreated assay media (Fig. S3) .
If decreased lrgAB expression is a contributor to the increased antimicrobial susceptibility seen in the DclpX mutant, we reasoned that overexpressing lrgAB on an exogenous plasmid in the DclpX mutant might rescue the phenotype. To test this, we complemented the DclpX mutant with either the expression plasmid pclpX or plrgAB. We compared the growth of wild-type B. anthracis Sterne containing empty plasmid (pUTE657), the DclpX mutant containing empty plasmid (pUTE657), the DclpX mutant complemented with pclpX, and the DclpX mutant complemented with plrgAB. Media were supplemented with 0.1 mM throughout the experiment, including overnight cultures, early log cultures and assay media, to ensure expression of pclpX and plrgAB in the DclpX mutant. All four strains grew to equal levels in untreated assay media (data not shown). As expected, the wild-type containing pUTE657 and DclpX complemented with pclpX grew well in media containing LL-37, but no growth was seen in either the DclpX mutant containing pUTE657 or DclpX containing plrgAB in media containing LL-37 (Fig. 5) . Therefore, while DlrgAB has some similar phenotypes to DclpX, it does not completely recapitulate them nor can overexpression of lrgAB replace the loss of clpX in the cell. anthracis Sterne resistance to LL-37 and daptomycin. Growth of wild-type parental B. anthracis Sterne with empty plasmid (WT (pUTE657)), the isogenic DlrgAB mutant with empty plasmid (DlrgAB (pUTE657)), and DlrgAB complemented with an LrgAB expression plasmid (DlrgAB (plrgAB)) in media containing (a) 1.6 µM LL-37 or (b) 8 µg ml À1 daptomycin. Statistically significant differences are represented by *P<0.05, as determined by one-way ANOVA followed by Tukey-Kramer post hoc analysis.
DISCUSSION
To our knowledge, only one other study has examined the transcriptome of a DclpX mutant, which was performed in Streptococcus mutans [8] . As was the case in S. mutans, the majority of disrupted genes in DclpX B. anthracis were involved in metabolic functions (energy, biosynthesis) followed by transport-related proteins. Contrary to what was seen in S. mutans, we find that the loss of clpX results in a higher prevalence of upregulated genes in B. anthracis. There were several differentially expressed genes uncovered in our microarray that have previously reported ties to cell wall-active antibiotics, including glpF, mrsA, sigM, lrgA and lrgB [21] [22] [23] [24] . We chose to focus on lrgA and lrgB because of the link with autolytic activity and penicillin resistance in S. aureus [21] .
Expression of lrgAB is significantly downregulated in our DclpX B. anthracis mutant, although the regulatory connection between them remains unknown. The two-component regulatory system LytSR and the transcriptional regulator CidR both positively regulate lrgAB [27, 28] , but their RNA expression in the DclpX mutant is not significantly changed. Unfortunately, lack of a commercial antibody prohibits us from examining expression at the protein level. We also cannot definitively say whether lrgAB regulation is due to ClpX activity as a chaperone or through its role as part of the ClpXP protease. However, previous microarray analysis comparing expression between wild-type and DclpP in S. aureus reported decreased expression of lrgAB in the DclpP mutant [9] . This finding suggests that the regulatory connection between ClpX and lrgAB is associated with ClpXP protease activity, as ClpP is not known to possess significant activity outside of a partnership with a regulatory ATPase such as ClpX [29] . These data also imply that the regulatory connection between ClpXP and lrgAB extends to at least one other bacterial species besides B. anthracis.
LrgAB has been studied in S. aureus [21, 26, [30] [31] [32] [33] and in B. anthracis Sterne [27, 28] , although there are subtle differences between the species. Neither we, nor a previous study [28] , saw an effect on autolytic activity after deletion of lrgAB in B. anthracis Sterne, contrary to what was seen in S. aureus [21] . We also see no effect on penicillin susceptibility in the DlrgAB B. anthracis Sterne mutant, even though the DlrgAB S. aureus mutant displays increased susceptibility [21] . This divergence could reflect different ways of performing the assays, or could be a true phenotypic difference between B. anthracis and S. aureus. Nonetheless, given that homology between B. anthracis and S. aureus LrgAB proteins is high [27] and that lrgAB has been linked to resistance to antimicrobials that target the cell wall and/or membrane in both species, we believe that LrgAB is likely to play a role in cell envelope physiology in B. anthracis as it does in S. aureus.
It is difficult to draw conclusions regarding the mechanism of action of LrgAB, based on the susceptibility of DlrgAB to LL-37 and daptomycin but not nisin and penicillin, because of overlapping targets between these antimicrobials. For example, both penicillin and nisin directly inhibit cell wall synthesis, through inhibition of either transpeptidation (penicillin) [34] or transglycosylation (nisin) [35] . However, nisin also forms pores in the bacterial membrane [35] as does LL-37 [36] . Furthermore, although LL-37 and daptomycin have traditionally been associated with their actions on the cell membrane [36, 37] , more recent evidence demonstrates that they also target the cell wall [38, 39] . Therefore, while DlrgAB has increased susceptibility to some cell envelope-targeting antimicrobials, it is not possible to differentiate whether this is due to defects in the cell membrane, cell wall or both.
While it is clear from our data that lrgAB expression is dependent on the presence of ClpX, the mechanistic link between these two genes is less clear. Both DclpX and DlrgAB show increased susceptibility to common antimicrobials (LL-37, daptomycin), although loss of clpX results in a stronger phenotype than loss of lrgAB. Their responses to other antimicrobials (nisin, penicillin) significantly diverge from one another, with increased susceptibility seen in DclpX but not DlrgAB. This difference in phenotypes is not entirely surprising, given that loss of clpX affects multiple genes besides lrgAB that may also contribute to antimicrobial resistance. In support of this, we find that overexpression of lrgAB is not sufficient to compensate for the loss of clpX, implying that pathways besides lrgAB contribute to the DclpX phenotype. Therefore, while decreased expression of lrgAB may be a contributing factor to the increased antimicrobial susceptibility seen in DclpX, it is by no means solely responsible for it. Future research will continue to look at pathways downstream of ClpX and their roles in antimicrobial resistance. DclpX complemented with either clpX (pclpX) or lrgAB (plrgAB) in media containing 1.6 µM LL-37. Statistically significant differences from wildtype growth are represented by *P<0.05, as determined by one-way ANOVA followed by Tukey-Kramer post hoc analysis.
